AC
IRON icon

Armistice Capital’s Disc Medicine IRON Stock Holding History

Armistice Capital’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.6M Sell
460,000
-76,000
-14% -$5.22M 0.41% 36
2026
Q1 		$34.3M Buy
536,000
+36,609
+7% +$2.54M 0.61% 27
2025
Q4 		$39.7M Buy
499,391
+63,391
+15% +$5.36M 0.47% 34
2025
Q3 		$28.8M Hold
436,000
– – 0.43% 37
2025
Q2 		$23.1M Hold
436,000
– – 0.4% 37
2025
Q1 		$21.6M Buy
436,000
+80,000
+22% +$4.45M 0.32% 60
2024
Q4 		$22.6M Buy
356,000
+196,000
+123% +$11.3M 0.31% 65
2024
Q3 		$7.86M Buy
+160,000
New +$7.51M 0.13% 102

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Armistice Capital's IRON Position: Q2 2026 in Review

Armistice Capital reduced its Disc Medicine (IRON) stake by 14% in Q2 2026, selling an estimated $5.22M and leaving 460,000 shares worth $33.6M. The position accounts for 0.41% of the portfolio, ranked #36.

Armistice Capital first reported a position in IRON in Q3 2024 and has held it in 8 quarters since. The position peaked at $39.7M in Q4 2025. 217 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Armistice Capital held 460,000 shares of Disc Medicine worth $33.6M as of Q2 2026.
  • Armistice Capital sold 76,000 Disc Medicine shares in Q2 2026, an estimated $5.22M.
  • Disc Medicine made up 0.41% of Armistice Capital's portfolio in Q2 2026, its #36 holding.
  • Armistice Capital first reported a position in Disc Medicine in Q3 2024 and has held it in 8 quarters since.
  • Armistice Capital's Disc Medicine position peaked at $39.7M in Q4 2025.
  • 217 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.